Advertisement

The MPTP model: an update

  • H. Russ
  • W. Mihatsch
  • H. Przuntek
Part of the Key Topics in Brain Research book series (KEYTOPICS)

Summary

MPTP is a neurotoxic agent which produces a parkinsonlike syndrome in humans and non-human primates by selective destruction of dopaminergic neurons in the nigrostriatal system. The two actual views on the mechanism of MPTP toxicity are the free radical theory and the theory of blocked energy metabolism. The chronic MPTP syndrome in old monkeys is in spite of some disagreements the best model of Parkinson’s disease which is available. The main experimental problems of the chronic MPTP model are the nutrition of the monkeys, the homogenity of the groups and the scoring of motor deficiency. The MPTP research results in new aspects for aetiology and treatment of Parkinson’s disease.

Keywords

Free Radical Theory MPTP Model Cerebrospinal Fluid Level MPTP Toxicity Motor Deficiency 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bakay RAE, Fiandaca MS, Barrow DL, Schiff A, Collins DC (1985) Preliminary report on the use of fetal tissue transplantation to correct MPTPinduced Parkinson-like syndrome in primates. Appl Neurophysiol 48: 358–361PubMedGoogle Scholar
  2. Chiba K, Trevor A, Castagnoli N (1985) Metabolism of the neurotoxic amine, MPTP by brain monoamine oxidase. Biochem Biophys Res Comm 120: 574–578CrossRefGoogle Scholar
  3. Corsini GU, Pintus S, Bocchetta A, Piccardi MP, Del Zompo M (1984) In vitro MAO type B dependent formation of an alkylating metabolite from 3H-MPTP in rat and monkey. In: Markey SP, Castagnoli N, Trevor AJ, Kopin IJ (eds) MPTP—A neurotoxin producing a parkinsonian syndrome. Academic Press, New York, pp 371–376Google Scholar
  4. Davis GC, Williams AC, Markey SP, Ebert MH, Calne ED, Reichert CM, Kopin IJ (1979) Chronic parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatr Res 1: 249–254CrossRefGoogle Scholar
  5. Forno LS, Langston JW, DeLanney LE, Irwin I, Ricaurte GA (1986) Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys. Ann Neurol 20: 449–455PubMedCrossRefGoogle Scholar
  6. Hirata Y, Nagatsu T (1985) Inhibition of tyrosin hydroxylation in tissue slices of the rat striatum by 1-methyl-4-phenyl-1,2, 3, 6-tetrahydropyridine. Brain Res 337: 193–196PubMedCrossRefGoogle Scholar
  7. Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic parkinsonism in human due to a product of meperidine-analog synthesis. Science 219: 979–980PubMedCrossRefGoogle Scholar
  8. Mihatsch W, Russ H, Przuntek H (1987) The effect of a protracted 1-methyl4-phenyl-1,2, 3, 6-tetrahydropyridine (MPTP)-application on marmoset. In: Nappi G, Agnoli A, Fariello R (eds) Neurotoxicology—basic and clinical research. International symposium on neurotoxicology, Turin, 1987. CIC Editioni InternationaliGoogle Scholar
  9. Nicklas WJ, Vyas I, Heikkila RE (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Life Sci 36: 2503–2508PubMedCrossRefGoogle Scholar
  10. Przuntek H, Russ H, Henning K, Pindur U (1985) The protective effect of 1-tert.butyl-4,4-diphenylpiperidine against the nigrostriatal neurodegeneration caused by 1-methyl-4-phenyl-1, 2,3, 6-tetrahydropyridine. Life Sci 37: 1195–1200PubMedCrossRefGoogle Scholar
  11. Riederer P, Youdim MBH (1987) MPTP induced dopaminergic neurotoxicity—a useful model in the study of Parkinson’s disease. Neurochem Int 11: 379–381PubMedCrossRefGoogle Scholar
  12. Russ H, Mihatsch W, Kuhn W, Przuntek H (1987) MPTP model of Parkinson’s disease in marmoset: radical scarvengers do not prevent neurodegeneration. J Neurochem 48 [Suppl]: 159Google Scholar

Copyright information

© Springer-Verlag/Wien 1989

Authors and Affiliations

  • H. Russ
    • 1
  • W. Mihatsch
    • 1
  • H. Przuntek
    • 2
  1. 1.Department of NeurologyUniversity of WürzburgFederal Republic of Germany
  2. 2.Department of NeurologySt. Josef University-HospitalBochumFederal Republic of Germany

Personalised recommendations